Processes to produce acalabrutinib
US11161851B2 · kind B2 · utility
1Cited by
0References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 5, 2018 |
| Grant date | Nov 2, 2021 |
| Priority date | — |
| Expiry date | Dec 18, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F5/025
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a method for preparing the compound of formula IV, compound of formula XI, and acalabrutinib, a new generation of bruton tyrosine kinase (BTK) inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.